SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950116-02-000920
Filing Date
2002-05-03
Accepted
2002-05-03 10:29:25
Documents
4
Period of Report
2002-01-16
Items
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eightk.txt 8-K 2516
3 EXHIBIT 10.1 ex10-1.txt EX-10 137007
4 EXHIBIT 10.2 ex10-2.txt EX-10 67384
5 EXHIBIT 10.3 ex10-3.txt EX-10 70646
  Complete submission text file 0000950116-02-000920.txt   279407
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 02632639
SIC: 2834 Pharmaceutical Preparations